194 related articles for article (PubMed ID: 21469769)
1. Comparative evaluation of the ViroSeq™ HIV-1 genotyping system and an in-house method for analysis of HIV-1 drug-resistance mutations in China.
Xu S; Zhong P; Li J; Song A; Li H; Nie J; Li X; Wang Y
Mol Diagn Ther; 2011 Feb; 15(1):41-52. PubMed ID: 21469769
[TBL] [Abstract][Full Text] [Related]
2. Comparison between an in-house method and the ViroSeq™ method for determining mutations for drug resistance in the HIV-1 CRF01_AE subtype circulating in China.
Li H; Liang S; Guo W; Zhuang D; Li L; Liu Y; Bao Z; Liu S; Wang X; Li T; Liu W; Li J
J Virol Methods; 2014 Sep; 205():17-23. PubMed ID: 24814966
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of an in-house human immunodeficiency virus (HIV) genotyping assay for the detection of drug resistance mutations in HIV-1 infected patients in Singapore.
Chew KK; Ng KY; Khong WX; Kaur P; Yap JK; Chua A; Tan MT; Koh YL; Thoon KC; Leo YS; Ng OT
Ann Acad Med Singap; 2012 Dec; 41(12):553-8. PubMed ID: 23303111
[TBL] [Abstract][Full Text] [Related]
4. Evaluations of an in-house drug resistance method for HIV-1 drug resistance using ViroSeq™ 2.0 genotyping system as a gold standard.
Chaturbhuj DN; Deshmukh PS; Hingankar NK; Siddhaarth K; Deshpande SN; Sen S; Kabra S; Paranjape RS; Tripathy SP
J Virol Methods; 2013 Apr; 189(1):87-92. PubMed ID: 23353551
[TBL] [Abstract][Full Text] [Related]
5. Performance comparison of an in-house integrase genotyping assay versus the ViroSeq™ Integra48, and study of HIV-1 integrase polymorphisms in Hong Kong.
To SW; Chen JH; Wong KH; Chan KC; Ng HM; Wu H; Lam JT; Yam WC
J Clin Virol; 2013 Sep; 58(1):299-302. PubMed ID: 23886504
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.
Sadeghi L; Lolaie M; Tabatabai RA; Bayanolhagh S; Taj L; Ahmadi NE; Abedinzadeh N; Vakili F; Ahmadi G; Mohraz M
Infect Disord Drug Targets; 2018; 18(3):241-248. PubMed ID: 29663899
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of HIV-1 primary drug resistance mutations in antiretroviral therapy-naive cases].
Yalçınkaya T; Köse S
Mikrobiyol Bul; 2014 Oct; 48(4):585-95. PubMed ID: 25492654
[TBL] [Abstract][Full Text] [Related]
8. Drug Resistance Mutations in a Population Before Antiretroviral Therapy Initiation in Northern South Africa.
Ogola B; Matume ND; Mavhandu-Ramarumo LG; Tebit DM; Bessong PO
AIDS Res Hum Retroviruses; 2022 Mar; 38(3):248-256. PubMed ID: 34107774
[TBL] [Abstract][Full Text] [Related]
9. [Drug resistance mutations and its associated factors among 579 HIV/AIDS patients experiencing failure of antiretroviral therapy in Jiangsu Province, China].
Xiao PP; Lu J; Hu HY; Xu XQ; Ding P; Fu GF; Huan XP; Zhou Y; Yang HT
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Nov; 51(11):988-993. PubMed ID: 29136743
[No Abstract] [Full Text] [Related]
10. High level of multidrug resistance mutations in HIV type 1 pol gene and resistance-associated mutations to enfuvirtide (T-20) among antiretroviral-experienced patients from central Brazil.
Cardoso LP; Stefani MM
AIDS Res Hum Retroviruses; 2009 Oct; 25(10):943-50. PubMed ID: 19792869
[TBL] [Abstract][Full Text] [Related]
11. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
[TBL] [Abstract][Full Text] [Related]
12. Protease and gag diversity and drug resistance mutations among treatment-naive Mexican people living with HIV.
Climaco-Arvizu S; Flores-López V; González-Torres C; Gaytán-Cervantes FJ; Hernández-García MC; Zárate-Segura PB; Chávez-Torres M; Tesoro-Cruz E; Pinto-Cardoso SM; Bekker-Méndez VC
BMC Infect Dis; 2022 May; 22(1):447. PubMed ID: 35538426
[TBL] [Abstract][Full Text] [Related]
13. Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria.
Santoro MM; Ciccozzi M; Alteri C; Montieri S; Alexiev I; Dimova I; Ceccherini-Silberstein F; Beshkov D; Rezza G; Perno CF
AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1133-8. PubMed ID: 18788909
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a Novel In-house HIV-1 Genotype Drug Resistance Assay using Clinical Samples in China.
Gao P; Yu F; Yang X; Li D; Shi Y; Wang Y; Zhang F
Curr HIV Res; 2022; 20(1):32-41. PubMed ID: 34515004
[TBL] [Abstract][Full Text] [Related]
15. Co-circulation HIV-1 subtypes B, C, and CRF31_BC in a drug-naïve population from Southernmost Brazil: analysis of primary resistance mutations.
de Medeiros RM; Junqueira DM; Matte MC; Barcellos NT; Chies JA; Matos Almeida SE
J Med Virol; 2011 Oct; 83(10):1682-8. PubMed ID: 21837783
[TBL] [Abstract][Full Text] [Related]
16. Distinct drug resistance profile of HIV-1 subtype A strain circulating in Georgia.
Dvali N; Chkhartishvili N; Karchava M; Sharvadze L; Tsertsvadze T
Georgian Med News; 2015 Mar; (240):19-24. PubMed ID: 25879553
[TBL] [Abstract][Full Text] [Related]
17. New trends of primary drug resistance among HIV type 1-infected men who have sex with men in Liaoning Province, China.
Zhao B; Han X; Dai D; Liu J; Ding H; Xu J; Chu Z; Bice T; Diao Y; Shang H
AIDS Res Hum Retroviruses; 2011 Oct; 27(10):1047-53. PubMed ID: 21417755
[TBL] [Abstract][Full Text] [Related]
18. Transmitted HIV-1 Drug Resistance in a Treatment-Naive Cohort of Recently Infected Individuals from Chennai, India.
Nesakumar M; Haribabu H; Cheedarla N; Karunaianantham R; Kailasam N; Sathyamurthi P; Selvachithiram M; Tripathy SP; Hanna LE
AIDS Res Hum Retroviruses; 2019 Aug; 35(8):775-779. PubMed ID: 31001987
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of drug resistance in therapy-naïve HIV infected patients and detection of African HIV subtypes in Hungary.
Kanizsai S; Ghidán A; Ujhelyi E; Bánhegyi D; Nagy K
Acta Microbiol Immunol Hung; 2010 Mar; 57(1):55-68. PubMed ID: 20350879
[TBL] [Abstract][Full Text] [Related]
20. Clade homogeneity and Pol gene polymorphisms in chronically HIV-1 infected antiretroviral treatment naive patients after the roll out of ART in Ethiopia.
Mulu A; Lange T; Liebert UG; Maier M
BMC Infect Dis; 2014 Mar; 14():158. PubMed ID: 24655349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
